Stand Up To Cancer Scientific Summit

Amanda Hollinger, HNCA Executive Director, attended the Stand Up to Cancer (SU2C) Scientific Summit in San Diego last month alongside 450 members of the SU2C community.

The annual SU2C Summit unites SU2C-funded researchers from multiple areas of study to allow the SU2C model of collaboration to realize its full potential. Top scientists share findings, ideas, and progress reports, thereby fostering greater discovery, increasing transparency, promoting additional collaboration across teams and research programs, and encouraging thinking outside the traditional research silos.

One of the projects discussed was the SU2C-Fanconi Anemia Research Fund-Farrah Fawcett Foundation Head and Neck Cancer Research Team which included additional support from American Head and Neck Society and the Head and Neck Cancer Alliance.

The goal of the project is to develop improved treatments for patients with head and neck cancer. This research is exploring combinations of existing and emerging treatments for head and neck squamous cell cancers (HNSCC), especially for people with the human papillomavirus (HPV) or Fanconi anemia.

The Head and Neck Cancer Alliance is excited to be involved with this cutting edge research alongside our other funding partners, said Hollinger. We know how desperately new treatments are needed for head and neck cancer. The research team brings together scientists approaching head and neck cancer from many different perspectives, and we look forward to keeping our community apprised of their discoveries and insights.

The Head and Neck Cancer Research team presents at SU2C. The team is led by Barbara Burtness, MD, Yale School of Medicine and Agata Smogorzewska, MD, PhD, The Rockefeller University. More information can be found here.